Standard
Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. / Lildballe, Dorte Launholt; Nguyen, Khoa Tran; Poulsen, Steen Seier; Nielsen, H O; Nexo, E.
In:
European Journal of Surgical Oncology, Vol. 37, No. 1, 01.01.2011, p. 72-79.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Lildballe, DL, Nguyen, KT
, Poulsen, SS, Nielsen, HO & Nexo, E 2011, '
Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma',
European Journal of Surgical Oncology, vol. 37, no. 1, pp. 72-79.
https://doi.org/10.1016/j.ejso.2010.11.001APA
Lildballe, D. L., Nguyen, K. T.
, Poulsen, S. S., Nielsen, H. O., & Nexo, E. (2011).
Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma.
European Journal of Surgical Oncology,
37(1), 72-79.
https://doi.org/10.1016/j.ejso.2010.11.001Vancouver
Lildballe DL, Nguyen KT
, Poulsen SS, Nielsen HO, Nexo E.
Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma.
European Journal of Surgical Oncology. 2011 Jan 1;37(1):72-79.
https://doi.org/10.1016/j.ejso.2010.11.001Author
Lildballe, Dorte Launholt ; Nguyen, Khoa Tran ; Poulsen, Steen Seier ; Nielsen, H O ; Nexo, E. / Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. In: European Journal of Surgical Oncology. 2011 ; Vol. 37, No. 1. pp. 72-79.
Bibtex
@article{8adb9717a8ae41ae900d04ade6b8e7a0,
title = "Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma",
abstract = "No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.",
keywords = "Adolescent, Carcinoma, Hepatocellular, Disease Progression, Humans, Liver Neoplasms, Male, Tomography, X-Ray Computed, Transcobalamins, Tumor Markers, Biological",
author = "Lildballe, {Dorte Launholt} and Nguyen, {Khoa Tran} and Poulsen, {Steen Seier} and Nielsen, {H O} and E Nexo",
note = "Copyright {\textcopyright} 2010 Elsevier Ltd. All rights reserved.",
year = "2011",
month = jan,
day = "1",
doi = "10.1016/j.ejso.2010.11.001",
language = "English",
volume = "37",
pages = "72--79",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
AU - Lildballe, Dorte Launholt
AU - Nguyen, Khoa Tran
AU - Poulsen, Steen Seier
AU - Nielsen, H O
AU - Nexo, E
N1 - Copyright © 2010 Elsevier Ltd. All rights reserved.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.
AB - No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.
KW - Adolescent
KW - Carcinoma, Hepatocellular
KW - Disease Progression
KW - Humans
KW - Liver Neoplasms
KW - Male
KW - Tomography, X-Ray Computed
KW - Transcobalamins
KW - Tumor Markers, Biological
U2 - 10.1016/j.ejso.2010.11.001
DO - 10.1016/j.ejso.2010.11.001
M3 - Journal article
C2 - 21111562
VL - 37
SP - 72
EP - 79
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
SN - 0748-7983
IS - 1
ER -
